Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome.

Down's syndrome (DS) has been considered a model of accelerated aging and of Alzheimer's disease. We investigated immunologic functions using peripheral blood leukocytes in order to correlate the production of cytokines and development of neuropathological changes of Alzheimer type in aged persons with DS. Cytokine production (IL-1beta, IL-2, IL-6, IL-8, and TNF-alpha), phytohemagglutinin (PHA)-stimulated proliferation of nonadherent monocytes, and superoxide anion production from polymorphonuclear leukocytes were measured. PHA-stimulated proliferation in aged individuals (>30 years old) with DS was significantly lower than that of age- and sex-matched controls (DS vs control, 55,707+/-5810 vs 88,310+/-6994 cpm, P < 0.001). PHA-stimulated IL-2 production was also significantly decreased in aged individuals with DS (DS vs control, 7.1+/-2.1 vs 10.7+/-1.3 ng/ml). Interestingly, the decrease of proliferation and IL-2 production in aged males with DS is significantly greater than in aged women with DS. PHA-stimulated proliferation and IL-2 production of nonadherent monocytes in females was not significantly reduced. IL-1beta production by LPS-activated adherent monocytes was significantly decreased in older adults with DS compared with non-DS controls. Other immune parameters measured in DS were not significantly different from that of age-matched controls. We conclude that there is partial impairment of T lymphocytes in aged persons with DS that is significantly greater in males than in females.

[1]  L. Stovner,et al.  Hormonal and biochemical disturbances in Down's syndrome. , 2008, Journal of mental deficiency research.

[2]  W. Weston,et al.  Phagocytic function in Down syndrome--II. Bactericidal activity and phagocytosis. , 2008, Journal of mental deficiency research.

[3]  F. Licastro,et al.  Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. , 2005, American journal of medical genetics. Supplement.

[4]  C. Franceschi,et al.  Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. , 2005, American journal of medical genetics. Supplement.

[5]  L. Notarangelo,et al.  Immunology of Down syndrome: a review. , 2005, American journal of medical genetics. Supplement.

[6]  B. Tycko,et al.  Earlier onset of Alzheimer's disease in men with Down syndrome , 1998, Neurology.

[7]  Z. Janka,et al.  Serum interleukin‐6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease , 1997, Acta neurologica Scandinavica.

[8]  E. Park,et al.  The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. , 1996, Immunopharmacology.

[9]  E. Park,et al.  Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells , 1993, Journal of leukocyte biology.

[10]  E. Novo,et al.  Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells. , 1993, American journal of medical genetics.

[11]  C B Harley,et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. , 1993, American journal of human genetics.

[12]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[14]  K. Holmen,et al.  Prevalence of Alzheimer's disease and other dementias in an elderly urban population , 1991, Neurology.

[15]  M. Oster-Granite,et al.  Abnormal production of interleukin-1 by microglia from trisomy 16 mice , 1991, Neuroscience Letters.

[16]  C. Franceschi,et al.  Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. , 1991, Blood.

[17]  R. Kaempfer,et al.  Aberrant regulation of interleukin-2 but not of interferon-gamma gene expression in Down syndrome (trisomy 21). , 1991, Clinical immunology and immunopathology.

[18]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[19]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[20]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. S. Williams,et al.  A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.

[22]  E. Kokmen,et al.  Alzheimer's disease and other dementing illnesses in a defined united states population: Incidence rates and clinical features , 1987, Annals of neurology.

[23]  Anthony F. Jorm,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[24]  J. Opitz,et al.  Gonadal function in patients with Down syndrome. , 1987, American journal of medical genetics.

[25]  A. Berger,et al.  Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). , 1986, Journal of immunology.

[26]  J. Pezzullo,et al.  Adolescent development in males with Down syndrome. , 1985, American journal of diseases of children.

[27]  C. Franceschi,et al.  THYMIC HORMONE DEFICIENCY IN NORMAL AGEING AND DOWN'S SYNDROME: IS THERE A PRIMARY FAILURE OF THE THYMUS? , 1984, The Lancet.

[28]  G. Annéren,et al.  Low Superoxide Levels in Blood Phagocytic Cells in Down's Syndrome , 1984, Acta paediatrica Scandinavica.

[29]  J. Ilonen,et al.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets. , 1984, Clinical and experimental immunology.

[30]  R. Walford.  Immunological Studies of Down's Syndrome and Alzheimer's Disease * , 1982, Annals of the New York Academy of Sciences.

[31]  S. Linna,et al.  Natural killer cell function in trisomy-21 (Down's syndrome). , 1982, Clinical and experimental immunology.

[32]  E. Korn,et al.  Altered cellular immune functions in patients with Down's syndrome. , 1981, American journal of diseases of children.

[33]  S. Segal,et al.  Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon , 1978, FEBS letters.

[34]  L. Heston,et al.  The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome. , 1977, Archives of general psychiatry.

[35]  A. Ugazio,et al.  Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages , 1975, European journal of immunology.

[36]  Robert W. Miller.  NEOPLASIA AND DOWNS SYNDROME , 1970 .

[37]  P. Fialkow.  THYROID AUTOIMMUNITY AND DOWN'S SYNDROME * , 1970 .

[38]  A. Dalton,et al.  Onset of dyspraxia in aging persons with Down syndrome: Longitudinal studies , 1998 .

[39]  R. Insoft,et al.  A hypothesis to explain the immune defects in Down syndrome. , 1995, Progress in clinical and biological research.

[40]  R. Philip,et al.  Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21). , 1987, Progress in clinical and biological research.

[41]  R. Warren,et al.  Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). , 1987, Immunological investigations.

[42]  H. Wiedemann,et al.  Clinical aspects of Down's syndrome from infancy to adult life. , 1981, Human genetics. Supplement.

[43]  L. Shapiro,et al.  Gonadal function in trisomy 21. , 1980, Hormone research.